| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shock, Cardiogenic | 11 | 2020 | 700 | 2.19 | Why? |
| Extracorporeal Membrane Oxygenation | 30 | 2021 | 5002 | 2.18 | Why? |
| Heart-Assist Devices | 7 | 2020 | 812 | 1.79 | Why? |
| Intra-Aortic Balloon Pumping | 3 | 2019 | 125 | 0.96 | Why? |
| Plasmapheresis | 2 | 2021 | 437 | 0.83 | Why? |
| Heart Transplantation | 9 | 2021 | 1293 | 0.77 | Why? |
| Femoral Vein | 1 | 2018 | 43 | 0.75 | Why? |
| Heart, Artificial | 1 | 2018 | 35 | 0.74 | Why? |
| Peripartum Period | 2 | 2018 | 89 | 0.70 | Why? |
| Extracorporeal Circulation | 1 | 2019 | 130 | 0.70 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.64 | Why? |
| Bioprosthesis | 1 | 2018 | 126 | 0.63 | Why? |
| Cardiomyopathies | 4 | 2018 | 997 | 0.61 | Why? |
| Prosthesis Implantation | 1 | 2018 | 261 | 0.61 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.57 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2018 | 552 | 0.55 | Why? |
| Aortic Valve | 2 | 2018 | 664 | 0.55 | Why? |
| Air Ambulances | 1 | 2017 | 202 | 0.52 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.52 | Why? |
| Heart Valve Diseases | 1 | 2018 | 355 | 0.51 | Why? |
| Heart Arrest | 3 | 2017 | 1239 | 0.47 | Why? |
| Heart Valve Prosthesis | 1 | 2018 | 533 | 0.46 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.44 | Why? |
| Heart Atria | 3 | 2018 | 267 | 0.44 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.39 | Why? |
| Postoperative Complications | 4 | 2021 | 5861 | 0.36 | Why? |
| Pulmonary Embolism | 3 | 2021 | 4775 | 0.32 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| France | 12 | 2021 | 12074 | 0.27 | Why? |
| Intensive Care Units | 10 | 2021 | 29594 | 0.26 | Why? |
| Adipose Tissue | 2 | 2018 | 612 | 0.24 | Why? |
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2019 | 11 | 0.20 | Why? |
| Type III Secretion Systems | 1 | 2018 | 10 | 0.20 | Why? |
| Xanthomonas | 1 | 2018 | 8 | 0.20 | Why? |
| Histocompatibility | 1 | 2019 | 53 | 0.20 | Why? |
| Mammary Arteries | 1 | 2019 | 31 | 0.19 | Why? |
| Tissue Donors | 3 | 2017 | 1679 | 0.19 | Why? |
| Hemangiosarcoma | 1 | 2018 | 24 | 0.19 | Why? |
| Thrombasthenia | 1 | 2018 | 12 | 0.19 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.19 | Why? |
| Amikacin | 1 | 2018 | 62 | 0.18 | Why? |
| Membranes, Artificial | 1 | 2020 | 175 | 0.18 | Why? |
| Pericardium | 2 | 2018 | 228 | 0.18 | Why? |
| Isoantibodies | 1 | 2019 | 134 | 0.18 | Why? |
| Embolism, Air | 1 | 2017 | 23 | 0.18 | Why? |
| Survival Rate | 5 | 2020 | 9206 | 0.17 | Why? |
| Fibrosis | 2 | 2018 | 800 | 0.17 | Why? |
| Atrial Remodeling | 1 | 2017 | 31 | 0.17 | Why? |
| Hemodynamics | 4 | 2020 | 1562 | 0.17 | Why? |
| Heart Neoplasms | 1 | 2018 | 77 | 0.17 | Why? |
| Hernia, Diaphragmatic | 1 | 2017 | 11 | 0.17 | Why? |
| Middle Aged | 41 | 2021 | 270681 | 0.17 | Why? |
| Male | 44 | 2021 | 367725 | 0.17 | Why? |
| Myocardial Infarction | 3 | 2018 | 3361 | 0.17 | Why? |
| Retrospective Studies | 18 | 2021 | 105322 | 0.17 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2017 | 91 | 0.16 | Why? |
| Heart Failure | 5 | 2018 | 6638 | 0.16 | Why? |
| Perioperative Period | 1 | 2018 | 276 | 0.16 | Why? |
| Vena Cava, Inferior | 1 | 2017 | 103 | 0.16 | Why? |
| Carotid Arteries | 1 | 2018 | 182 | 0.16 | Why? |
| Female | 41 | 2021 | 380317 | 0.16 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2019 | 260 | 0.16 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.16 | Why? |
| HLA Antigens | 2 | 2019 | 830 | 0.16 | Why? |
| Graft Survival | 1 | 2019 | 587 | 0.15 | Why? |
| Tomography | 1 | 2017 | 183 | 0.15 | Why? |
| Myocardium | 2 | 2018 | 2323 | 0.15 | Why? |
| Brain Death | 1 | 2017 | 146 | 0.15 | Why? |
| Ventricular Dysfunction | 1 | 2016 | 150 | 0.15 | Why? |
| Microcirculation | 1 | 2020 | 447 | 0.15 | Why? |
| Calcinosis | 1 | 2018 | 240 | 0.15 | Why? |
| Central Venous Catheters | 1 | 2017 | 188 | 0.15 | Why? |
| Withholding Treatment | 1 | 2021 | 798 | 0.15 | Why? |
| Paris | 4 | 2021 | 1287 | 0.14 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.14 | Why? |
| Electric Impedance | 1 | 2017 | 283 | 0.14 | Why? |
| Adult | 32 | 2021 | 244371 | 0.14 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.14 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 231 | 0.14 | Why? |
| Aorta | 1 | 2018 | 355 | 0.14 | Why? |
| Ambulances | 1 | 2017 | 287 | 0.14 | Why? |
| Cardiac Tamponade | 1 | 2017 | 165 | 0.13 | Why? |
| Graft Rejection | 3 | 2019 | 1766 | 0.13 | Why? |
| Desensitization, Immunologic | 1 | 2019 | 574 | 0.13 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.13 | Why? |
| Coronary Artery Disease | 2 | 2019 | 2570 | 0.13 | Why? |
| Humans | 53 | 2021 | 930598 | 0.13 | Why? |
| Myocarditis | 2 | 2020 | 2731 | 0.13 | Why? |
| Propensity Score | 2 | 2018 | 2690 | 0.12 | Why? |
| Pulmonary Edema | 1 | 2017 | 430 | 0.12 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.12 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.12 | Why? |
| Catheterization, Central Venous | 1 | 2017 | 458 | 0.12 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.12 | Why? |
| Survival Analysis | 3 | 2021 | 7592 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2020 | 993 | 0.11 | Why? |
| Waiting Lists | 2 | 2018 | 1388 | 0.11 | Why? |
| Ventilator Weaning | 1 | 2016 | 536 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.11 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.11 | Why? |
| Donor Selection | 1 | 2017 | 804 | 0.11 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.10 | Why? |
| Heparin | 2 | 2020 | 2600 | 0.10 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.10 | Why? |
| Stents | 1 | 2018 | 916 | 0.10 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.10 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2020 | 6653 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Aged | 19 | 2021 | 215776 | 0.10 | Why? |
| Thrombocytopenia | 2 | 2020 | 2093 | 0.10 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.10 | Why? |
| Aortic Valve Stenosis | 1 | 2018 | 741 | 0.10 | Why? |
| Follow-Up Studies | 5 | 2021 | 17020 | 0.10 | Why? |
| Positive-Pressure Respiration | 1 | 2017 | 1160 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.09 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2019 | 2705 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.08 | Why? |
| Critical Illness | 3 | 2018 | 17281 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2020 | 6551 | 0.07 | Why? |
| von Willebrand Factor | 2 | 2021 | 668 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.07 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2017 | 1876 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.06 | Why? |
| Renal Dialysis | 1 | 2020 | 4358 | 0.06 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Risk Assessment | 4 | 2019 | 25439 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.06 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.06 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
| Asthenia | 1 | 2020 | 107 | 0.05 | Why? |
| Transplant Recipients | 1 | 2017 | 4982 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Coronary Angiography | 2 | 2020 | 2275 | 0.05 | Why? |
| Tachycardia | 1 | 2020 | 239 | 0.05 | Why? |
| Mutagenesis, Insertional | 1 | 2018 | 92 | 0.05 | Why? |
| Veins | 1 | 2020 | 168 | 0.05 | Why? |
| Coronary Care Units | 1 | 2020 | 224 | 0.05 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2019 | 100 | 0.05 | Why? |
| Infusion Pumps | 1 | 2018 | 44 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Seeds | 1 | 2018 | 114 | 0.04 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.04 | Why? |
| Arteries | 1 | 2020 | 283 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2019 | 389 | 0.04 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.04 | Why? |
| Hypotension | 1 | 2020 | 392 | 0.04 | Why? |
| Platelet Transfusion | 1 | 2018 | 209 | 0.04 | Why? |
| Tobacco | 1 | 2018 | 274 | 0.04 | Why? |
| Conjunctivitis | 1 | 2020 | 318 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.04 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.04 | Why? |
| Equipment Failure | 1 | 2017 | 197 | 0.04 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.04 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.04 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2017 | 357 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
| Laparotomy | 1 | 2017 | 241 | 0.03 | Why? |
| Abdominal Pain | 1 | 2020 | 858 | 0.03 | Why? |
| Tidal Volume | 1 | 2017 | 565 | 0.03 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.03 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.03 | Why? |
| Intestinal Obstruction | 1 | 2017 | 197 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Mitral Valve Insufficiency | 1 | 2017 | 302 | 0.03 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.03 | Why? |
| Postpartum Period | 1 | 2018 | 936 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Myocytes, Cardiac | 1 | 2017 | 804 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Exanthema | 1 | 2020 | 1097 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 2309 | 0.03 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.03 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.02 | Why? |
| Tertiary Care Centers | 2 | 2017 | 8248 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Thrombophilia | 1 | 2018 | 1935 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.02 | Why? |
| Hospital Mortality | 2 | 2019 | 22087 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.02 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Germany | 1 | 2018 | 9196 | 0.01 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.01 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Lung | 1 | 2017 | 31049 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.00 | Why? |